Off-the-Shelf CAR-NK cells engineered to express calibrated release IL-15 exhibit enhanced persistence and anti-tumor activities

被引:0
|
作者
Lee, Chen-Ting
Hung, Michelle
Banicki, Andrew
Song, Wenqi
Almudhfar, Niran
Kaveri, Deepika
Wong, Priscilla
Naitmazi, Lawrence
Guzman, Marcela
Lam, Alice
Yucel, Gozde
Lu, Timothy
Junca, Alba G.
Garrison, Brian
Lee, Philip
机构
关键词
D O I
10.1158/1538-7445.AM2023-2902
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2902
引用
收藏
页数:2
相关论文
共 50 条
  • [31] REGULATION OF CYTOKINE RELEASE AND ANTI-TUMOR EFFECT OF ANTI-CD20 CAR MODIFIED EXPANDED NATURAL KILLER CELLS BY ALT-803, AN IL-15 SUPERAGONIST
    Chu, Yaya
    Lee, Fangyu
    Hamby, Carl
    Misarti, Jesse
    Hang, Brian
    Ayello, Janet
    Zhang, Melanie
    Zhu, Hongwen
    Wong, Hing
    Lee, Dean
    Cairo, Mitchell
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S64 - S64
  • [32] Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by ALT-803, an Il-15 superagonist
    Chu, Yaya
    Su, Nang Kham
    Hamby, Carl
    Jeng, Emily K.
    Alter, Sarah
    Barth, Mathew
    Wong, Hing C.
    Lee, Dean A.
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 57 - 57
  • [33] piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
    Du, Zhicheng
    Ng, Yu Yang
    Zha, Shijun
    Wang, Shu
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 582 - 596
  • [34] IL-2 and IL-15 allow the generation of gamma-delta CAR-T cells with potent anti-leukaemia activity: A foundation for off-the-shelf cellular immunotherapy of haematological malignancies
    Doglio, M.
    Casucci, M.
    Falcone, L.
    Camisa, B.
    Ciceri, F.
    Bonini, C.
    Frassoni, F.
    Bondanza, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S166 - S166
  • [35] GENETICALLY ENGINEERED TUMOR-INFILTRATING LYMPHOCYTES (CYTOTIL15) EXHIBIT IL-2-INDEPENDENT PERSISTENCE AND ANTI-TUMOR EFFICACY AGAINST MELANOMA IN VIVO
    Burga, Rachel
    Khattar, Mithun
    Lajoie, Scott
    Pedro, Kyle
    Foley, Colleen
    Ocando, Alonso Villasmil
    Tremblay, Jack
    Primack, Benjamin
    Langley, Meghan
    Thornton, Dan
    Tam, Stanley
    Brideau, Emily
    Ross, Theresa
    Wilmes, Gwen
    Saha, Sunandan
    Helmlinger, Gabriel
    Tchaicha, Jeremy
    Sethi, Dhruv
    Ols, Michelle
    Vanasse, Gary
    Subramanian, Shyam
    ter Meulen, Jan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A176 - A176
  • [36] HUMAN ALLOGENEIC NK CELLS MODIFIED TO EXPRESS A TGF-β DOMINANT NEGATIVE RECEPTOR AND IL-15 DISPLAY A STRONG ANTI-TUMOR ACTIVITY IN AN NSG MOUSE MODEL OF HUMAN MESOTHELIOMA
    Bonan, N.
    Chen, J.
    Ghofrani, J. T.
    Medina, J. A.
    Bollard, C.
    Yvon, E.
    Fernandes, R.
    CYTOTHERAPY, 2022, 24 (05) : S40 - S40
  • [37] Glypican-3-Specific CAR NKT Cells Armored with IL-15 Mediate Potent Anti-Tumor Response Against Hepatocellular Carcinoma
    Shaik, Rahamthulla
    Rathi, Purva
    Schneller, Netta
    Thao Nguyen
    Guo, Linjie
    Courtney, Amy
    Fleurence, Julien
    Metelitsa, Leonid
    Heczey, Andras
    MOLECULAR THERAPY, 2020, 28 (04) : 34 - 35
  • [38] Human Allogenic NK Cells Modified to Express a TGF-B Dominant Negative Receptor and IL-15 Display a Strong Anti-Tumor Activity in an NSG Mouse Model of Human Mesothelioma
    Bonan, Nicole
    Chen, Jie
    Ghofrani, Joshua T.
    Medina, Jacob A.
    Bollard, Catherine M.
    Fernandes, Rohan J.
    Yvon, Eric
    MOLECULAR THERAPY, 2022, 30 (04) : 506 - 506
  • [39] THE MULTI-OMICS ANALYSES OF "OFF-THE-SHELF" CD19-CAR-T CELLS IDENTIFIES THE SUBPOPULATION COMPLEXITY AND THE DEEP CHARACTERIZATION OF THE ANTI-TUMOR PROPERTIES
    Al Sulaiti, Asma
    El-Anbari, Mohammed
    Jacob, Shana
    Mohamed, Toufiq
    Balayya, Saroja Kotegar
    Mohan, Suruchi
    Olagunju, Damilola
    Cugno, Chiara
    Deola, Sara
    Grivel, Jean-Charles
    Chaussabel, Damien
    Bonini, Chiara
    Casucci, Monica
    Maccalli, Cristina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A433 - A433
  • [40] THE INTEGRATED MULTI-OMIC CHARACTERIZATION OF ''OFF-THE-SHELF'' CD19-CAR-T CELLS ALLOWS THE IDENTIFICATION OF ENGINEERED CELLS ENDOWED WITH SUPERIOR ANTI-TUMOR FITNESS AND LOWER PRO-INFLAMMATORY ACTIVITY
    Al Sulaiti, A.
    El Anbari, M.
    Toufiq, M.
    Jacob, S.
    Balayya, S. Kotegar
    Chin-Smith, E.
    Mohan, S.
    Olagunju, D.
    Cugno, C.
    Deola, S.
    Chaussabel, D.
    Bonini, C.
    Casucci, M.
    Maccalli, C.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A30 - A31